These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Experimental allergic encephalomyelitis. V. Therapeutic attempts with immunosuppressive and antiinflammatory drugs. Anghelescu N; Petrescu A; Chimion D Neurol Psychiatr (Bucur); 1979; 17(2):99-105. PubMed ID: 482840 [No Abstract] [Full Text] [Related]
4. [Immunosuppressive treatment in neurological disorders]. Aarli JA Tidsskr Nor Laegeforen; 1973 Jun; 93(18):1395-7. PubMed ID: 4356438 [No Abstract] [Full Text] [Related]
5. Immune-based therapy of multiple sclerosis. Kaufman MD N C Med J; 1995 Aug; 56(8):379-84. PubMed ID: 7566191 [No Abstract] [Full Text] [Related]
6. Effect of various immunosuppressive drugs on experimental allergic encephalomyelitis in chickens. Blaszczyk B; Karakoz I; Gieldanowski J Folia Biol (Praha); 1977; 23(6):398-9. PubMed ID: 608476 [No Abstract] [Full Text] [Related]
7. [Prevention of experimental allergic encephalomyelitis by immunological technics]. Pellet H; Brun M; Camargo R; Girard P Rev Neurol (Paris); 1968 Feb; 118(2):133-40. PubMed ID: 4301748 [No Abstract] [Full Text] [Related]
8. Chemotherapy of experimental allergic encephalomyelitis (EAE). Rosenthale ME; Datko LJ; Kassarich J; Schneider F Arch Int Pharmacodyn Ther; 1969 Jun; 179(2):251-75. PubMed ID: 5367302 [No Abstract] [Full Text] [Related]
9. The influence of cinanserin and selected pharmacologic agents on experimental allergic encephalomyelitis (EAE). Babington RG; Wedeking PW J Pharmacol Exp Ther; 1971 May; 177(2):454-60. PubMed ID: 4254977 [No Abstract] [Full Text] [Related]
10. Suppression of experimental allergic encephalomyelitis by NSC 82196, a new imidazole carboxamide derivative. Vogel CL; De Vita VT; Lisak RP; Kies MW Cancer Res; 1969 Dec; 29(12):2249-53. PubMed ID: 5369677 [No Abstract] [Full Text] [Related]
11. Neuroimmunology of multiple sclerosis and experimental allergic encephalomyelitis. Stuerzebecher S; Martin R Neuroimaging Clin N Am; 2000 Nov; 10(4):649-68 ,vii-viii. PubMed ID: 11359717 [TBL] [Abstract][Full Text] [Related]
12. 2 [(methylsulfinyl) acetyl] pyridine (Oxisuran): a new immunosuppressive agent in EAE. Caputo D; Altamura C; Bisaccia G; Ghezzi A; Manara F; Zibetti A Boll Ist Sieroter Milan; 1978 Sep; 57(4):422-7. PubMed ID: 581646 [TBL] [Abstract][Full Text] [Related]
13. [Current data on the etiopathogenesis of multiple sclerosis]. Duca E Neurol Psihiatr Neurochir; 1972; 17(5):385-94. PubMed ID: 4632587 [No Abstract] [Full Text] [Related]
14. New insights into cell responses involved in experimental autoimmune encephalomyelitis and multiple sclerosis. El Behi M; Dubucquoi S; Lefranc D; Zéphir H; De Seze J; Vermersch P; Prin L Immunol Lett; 2005 Jan; 96(1):11-26. PubMed ID: 15585303 [TBL] [Abstract][Full Text] [Related]
15. [Modern therapeutic viewpoints in the treatment of multiple sclerosis]. Neumayer E Wien Med Wochenschr; 1969 Apr; 119(15):281-4. PubMed ID: 5769603 [No Abstract] [Full Text] [Related]
16. Quinpramine: revival of old anti-inflammatory principles in multiple sclerosis? Haghikia A; Gold R Exp Neurol; 2009 Jun; 217(2):240-1. PubMed ID: 19361499 [No Abstract] [Full Text] [Related]
17. Glatiramer acetate (Copaxone). Francis DA Int J Clin Pract; 2001; 55(6):394-8. PubMed ID: 11501229 [TBL] [Abstract][Full Text] [Related]